Rutinoscorbin vitamin supplement

Rutinoscorbin is a well-known medicinal product primarily used in Poland to support immunity and treat vitamin C and rutoside deficiencies. The brand has a long-standing history in the Polish pharmaceutical market, originally developed by local pharmaceutical entities.

The brand has undergone changes in corporate ownership due to global pharmaceutical mergers and spin-offs. Historically associated with GlaxoSmithKline (GSK), it became part of Haleon following the demerger of GSK's consumer healthcare business in 2022. Today, Haleon, a British multinational consumer healthcare company, is the ultimate owner. Production is predominantly based in Poland, specifically in Poznań, to serve the local and regional European markets.